Q2 2021

Source filing unavailable

Q2 2021 · —

Revenue—

Net Income

-$100.43M

N/M vs Q2 2020

EPS Diluted

-$4.90

no prior Q2 2020 on file

Operating Income-$99,491,000—

Operating Cash Flowderived-$92,865,000—

Free Cash Flowderived

Same quarter

Metric	Q2 2021	Q2 2020
Net Income	-$100.43M	-$2.51M
EPS Diluted	-$4.90	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

LianBio · CIK 1831283 · Engraved from SEC EDGAR